1. Therapeutic Applications of Radiopharmaceuticals IAEA, Vienna, 2001 IAEA-TECDOC-1228.
2. Zhen W, Yin Z, Yinghui G, Huijuan I, Yanhui L, Jiajun Z, et al. Therapeutic response of radiosynovectomy with P-32 colloid in 326 patients with hemophilic arthropathy. Chin J Hematol. 2017;38:39–43.
3. Resche I, Chatal JF, Pecking A, Ell P, Duchesne G, Rubens R, et al. A dose controlled study of 153Sm-EDTMP in the treatment of patients with painful bone metastases. Eur J Cancer. 1997;33:1583–91.
4. Lassmann M, Hänscheid H, Chiesa Cİ, Hindorf C, Flux G, Luster M. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy. Eur J Nucl Med Mol Imaging. 2008;35:1405–12.
5. Liepe K, Hliscs R, Kropp J, Runge R, Knapp FF, Franke WG. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases. J Nucl Med. 2003;44:953–60.